EP 1943220 A2 20080716 - INDOLE-CONTAINING BETA AGONISTS, METHOD FOR PRODUCING THEM AND THEIR USE AS DRUGS
Title (en)
INDOLE-CONTAINING BETA AGONISTS, METHOD FOR PRODUCING THEM AND THEIR USE AS DRUGS
Title (de)
INDOL-HALTIGE BETA-AGONISTEN, VERFAHREN ZU DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS ARZNEIMITTEL
Title (fr)
BETA ANTAGONISTES CONTENANT DE L'INDOLE, PROCEDE DE PRODUCTION ASSOCIE ET UTILISATION EN TANT QUE MEDICAMENTS
Publication
Application
Priority
- EP 2006067872 W 20061027
- DE 102005052127 A 20051028
Abstract (en)
[origin: WO2007048841A2] The invention relates to the novel beta agonists of formula (I), wherein R<SUP>1</SUP> and R<SUP>2</SUP> are defined as in the claims and the description. The invention also relates to the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, or mixtures thereof, to their prodrugs and their salts, especially their physiologically acceptable salts with inorganic or organic acids or bases, to a method for producing said compounds and to their use as drugs.
IPC 8 full level
C07D 403/04 (2006.01); C07D 209/08 (2006.01); C07D 209/18 (2006.01); C07D 209/42 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 413/12 (2006.01)
CPC (source: EP KR US)
A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/12 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 1/18 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 13/00 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 13/10 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 209/08 (2013.01 - EP US); C07D 209/18 (2013.01 - EP US); C07D 209/42 (2013.01 - EP KR US); C07D 401/12 (2013.01 - EP KR US); C07D 403/04 (2013.01 - EP US); C07D 403/12 (2013.01 - EP US); C07D 405/12 (2013.01 - EP KR US); C07D 413/12 (2013.01 - EP US)
Citation (search report)
See references of WO 2007048841A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
DE 102005052127 A1 20070503; AR 058162 A1 20080123; AU 2006307907 A1 20070503; BR PI0617851 A2 20110809; CA 2627486 A1 20070503; CN 101296903 A 20081029; EP 1943220 A2 20080716; JP 2009514817 A 20090409; KR 20080065674 A 20080714; PE 20070694 A1 20070821; TW 200800187 A 20080101; US 2007105906 A1 20070510; US 7754756 B2 20100713; UY 29883 A1 20070531; WO 2007048841 A2 20070503; WO 2007048841 A3 20070621; ZA 200803116 B 20090930
DOCDB simple family (application)
DE 102005052127 A 20051028; AR P060104696 A 20061027; AU 2006307907 A 20061027; BR PI0617851 A 20061027; CA 2627486 A 20061027; CN 200680040338 A 20061027; EP 06807619 A 20061027; EP 2006067872 W 20061027; JP 2008537111 A 20061027; KR 20087012694 A 20080527; PE 2006001303 A 20061026; TW 95139913 A 20061027; US 55083006 A 20061019; UY 29883 A 20061025; ZA 200803116 A 20080409